Kevin Judice

Kevin Judice discloses dealings in DICE Therapeutics, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 3 May 2023 and the latest from 9 August 2023.

Sales make up the whole of the open-market record (1 sale, €452k).

The latest filing, published on 9 August 2023, reports a transaction in DICE Therapeutics, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.